David P. Wales

Skadden, Arps, Slate, Meagher & Flom (Washington DC)
Lawyer (Partner)

David Wales is a Partner at Skadden. Previously the Global Chair of Antitrust Practice at Jones Day, David Wales has extensive antitrust experience in both the private and public sectors. He represents foreign and domestic clients in a wide range of industries on all aspects of antitrust, including mergers and acquisitions, criminal grand jury investigations, dominant firm conduct, distribution arrangements, licensing, and competitor collaborations. Dave has the unique experience of serving as a senior official in both U.S. antitrust agencies. He spent three years at the Federal Trade Commission and, from 2008 to 2009, oversaw all of the agency’s antitrust enforcement as acting director of the Bureau of Competition. Dave was involved with many industries at the FTC, including pharmaceuticals, health care, energy, chemicals, defense, retail, consumer products, and high-technology. Major matters handled during his tenure included Whole Foods’ acquisition of Wild Oats, CCC’s acquisition of Mitchell, lawsuits against Cephalon and Solvay Pharmaceuticals for exclusion payment agreements, and Inova’s acquisition of Prince William Hospital. From 2001 to 2003, Dave was counsel to the assistant attorney general in the Department of Justice’s Antitrust Division, where he was part of the team overseeing all antitrust matters before the agency, including the Microsoft case, the DIRECTV/Echostar merger, and Northrop Grumman’s acquisition of TRW. Prior to his recent government tenure, Dave was an antitrust partner with Cadwalader, Wickersham & Taft and Shearman & Sterling. Dave has testified on antitrust policy issues before the U.S. Congress and the Antitrust Modernization Committee. He regularly speaks and writes on antitrust and has had various leadership positions in the American Bar Association’s Antitrust Section.

Distinctions

Linked authors

Jones Day (Sillicon Valley)
Jones Day (Washington DC)
Jones Day (Washington DC)
Jones Day (Houston)
Jones Day (Washington DC)
Jones Day (Chicago)
Jones Day (Washington DC)
Jones Day (Cleveland)

Articles

4684 Bulletin

David P. Wales, J. Bruce McDonald, John M. Majoras, Kathryn M. Fenton, Michelle K. Fischer, Ryan C. Thomas, Stephen J. Squeri The U.S. Department of Justice Antitrust Division considers individual civil enforcement actions against executives implicated in corporate wrongdoing (Yates Memo)

102

The U.S. Department of Justice Antitrust Division will consider individual civil enforcement actions against executives implicated in corporate wrongdoing, according to recent comments by DOJ Assistant U.S. Attorney General Bill Baer. His comments follow a September 2015 memo, "Individual (...)

David P. Wales, Kathryn M. Fenton, Michael H. Knight, Paula W. Render, Thomas D. York The Federal Trade Commission revises the Merger rules which implements automatic atay of Administrative litigation when Agency loses preliminary injunction in Court

67

One important procedural difference between merger challenges by the U.S. Department of Justice and the Federal Trade Commission is that FTC may challenge a non-consummated merger through both a district court preliminary injunction and administrative litigation (Part 3 adjudication). Recent (...)

Craig Waldman, David P. Wales, Geoffrey D. Oliver The US FTC proposes acquisition consent agreement to resolve unprecedented allegations on enforcement of standards-essential patents (Bosch / SPX)

370

The U.S. Federal Trade Commission this week announced a highly unusual proposed consent agreement reached with Robert Bosch GmbH ("Bosch") that permits Bosch’s acquisition of SPX Service Solutions U.S. LLC ("SPX Service Solutions") from SPX Corporation ("SPX") to proceed. More significantly, it (...)

David P. Wales, J. Bruce McDonald, Kathryn M. Fenton The U.S. Court of Appeals for the District of Columbia Circuit upholds FTC subpoena in investigation into bundling and exclusionary practices (Church & Dwight)

101

A unanimous panel of the U.S. Court of Appeals for the District of Columbia Circuit upheld a district court decision enforcing the Federal Trade Commission’s administrative subpoena and civil investigative demand in an ongoing FTC investigation. The December 13, 2011, opinion is noteworthy (...)

David P. Wales, Geoffrey D. Oliver, Michael H. Knight The U.S. FTC sues to undo completed acquisition in the healthcare industry approved by bankruptcy court (LabCorp / Westcliff)

502

The Federal Trade Commission has filed an administrative lawsuit seeking to undo Laboratory Corporation of America’s (« LabCorp ») acquisition of Westcliff Medical Laboratories, Inc. (« Westcliff »). According to the agency’s December 1 complaint, the merger will substantially lessen competition (...)

David P. Wales, Geoffrey D. Oliver, Michael H. Knight The US FTC sues to undo completed acquisition in the healthcare industry approved by bankruptcy court (LabCorp, Westcliff)

83

The Federal Trade Commission has filed an administrative lawsuit seeking to undo Laboratory Corporation of America’s (« LabCorp ») acquisition of Westcliff Medical Laboratories, Inc. (« Westcliff »). According to the agency’s December 1 complaint, the merger will substantially lessen competition (...)

Send a message